Literature DB >> 1332057

Ligand-induced phosphorylation of the murine interleukin 3 receptor signals its cleavage.

A L Mui1, R J Kay, R K Humphries, G Krystal.   

Abstract

The murine interleukin 3 receptor (mIL-3R) is a heterodimer consisting of a 70-kDa alpha subunit and one of two alternative 120-kDa beta subunits termed beta IL-3 and beta c. beta IL-3 (originally called Aic2A) is capable of binding mIL-3 by itself, whereas beta c (Aic2B) does not bind any ligand on its own but increases the affinity of mIL-3, murine granulocyte/macrophage-colony-stimulating factor, and mIL-5 for their respective alpha subunits. Interestingly, although the mIL-3R does not possess tyrosine kinase activity, its beta IL-3 subunit does become tyrosine phosphorylated upon binding mIL-3. To further investigate the properties of this subunit, we have purified it from the cell line B6SUtA1, which expresses a high level of mIL-3R. Intriguingly, studies comparing the stability of the 140-kDa, tyrosine-phosphorylated form of this subunit with its 120-kDa, non-tyrosine-phosphorylated form reveal that the former is far less stable and is rapidly degraded to a 70-kDa fragment. Mixing experiments demonstrate that the differential stability of the two forms is due to an intrinsic difference in protease susceptibility. Phosphatase studies indicate that the higher protease susceptibility of the tyrosine-phosphorylated beta IL-3 is due to the presence of both phosphotyrosine and phosphoserine residues. Western analyses using an anti-N-terminal mIL-3R beta IL-3 chain antibody reveal that this proteolytic cleavage also occurs rapidly in intact cells following stimulation with mIL-3 and occurs at the cell surface, since it takes place within minutes at 37 degrees C, is observed with purified plasma membranes, and is not inhibited by chloroquine. This degradative step may play an important role in the mechanism of action of mIL-3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332057      PMCID: PMC50432          DOI: 10.1073/pnas.89.22.10812

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  Cytokine receptors and signal transduction.

Authors:  A Miyajima; T Kitamura; N Harada; T Yokota; K Arai
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Purification of the murine interleukin 3 receptor.

Authors:  A L Mui; R J Kay; R K Humphries; G Krystal
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

Review 3.  Hematopoietic growth factor receptors.

Authors:  G Krystal; M Alai; R L Cutler; H Dickeson; A L Mui; A W Wognum
Journal:  Hematol Pathol       Date:  1991

4.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

5.  Characterization of the interleukin 3 receptor.

Authors:  S C Murthy; A L Mui; G Krystal
Journal:  Exp Hematol       Date:  1990-01       Impact factor: 3.084

6.  Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family.

Authors:  D M Gorman; N Itoh; T Kitamura; J Schreurs; S Yonehara; I Yahara; K Arai; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines.

Authors:  J S Greenberger; M A Sakakeeny; R K Humphries; C J Eaves; R J Eckner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line.

Authors:  J Damen; A L Mui; P Hughes; K Humphries; G Krystal
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

9.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis.

Authors:  O Miura; A D'Andrea; D Kabat; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.

Authors:  G B Mills; C May; M McGill; M Fung; M Baker; R Sutherland; W C Greene
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

View more
  6 in total

1.  Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc.

Authors:  L Liu; J E Damen; R L Cutler; G Krystal
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

2.  Immune complexes (IC) down-regulate the basal and interferon-gamma-induced expression of MHC class II on human monocytes.

Authors:  P Barrionuevo; M Beigier-Bompadre; S De La Barrera; M F Alves-Rosa; G Fernandez; M S Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis.

Authors:  T Yi; A L Mui; G Krystal; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

4.  Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infection.

Authors:  R Raqib; A A Lindberg; L Björk; P K Bardhan; B Wretlind; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

5.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

6.  IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.

Authors:  S Sato; T Katagiri; S Takaki; Y Kikuchi; Y Hitoshi; S Yonehara; S Tsukada; D Kitamura; T Watanabe; O Witte; K Takatsu
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.